gamma-aminobutyric Acid (GABA) A Receptor, pi (GABRP) Peptide
-
- Target See all GABRP products
- GABRP (gamma-aminobutyric Acid (GABA) A Receptor, pi (GABRP))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- GFENLTAGYN KFLRPNFGGD PVRIALTLDI ASISSISESN MDYTATIYLR
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of Gabrp antibody,
Alternative Names: Gabrp control peptide, Gabrp antibody Blocking Peptide, Anti-Gabrp Blocking Peptide, gamma-aminobutyric acid, GABA A receptor, pi Blocking Peptide, MGC38123 Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- GABRP (gamma-aminobutyric Acid (GABA) A Receptor, pi (GABRP))
- Background
- GABA, the major inhibitory neurotransmitter in the vertebrate brain, mediates neuronal inhibition by binding to the GABA/benzodiazepine receptor and opening an integral chloride channel. In the uterus, the function of the receptor appears to be related to tissue contractility. The binding of this pI subunit with other GABA(A) receptor subunits alters the sensitivity of recombinant receptors to modulatory agents such as pregnanolone.
- Molecular Weight
- 50 kDa
-